investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer
Brett Stewart Carver
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Bingcheng Wang
EphA2 kinase in prostate cancer
Prostate
Peter Blumberg
Molecular Mechanism of Action of Phorbol Ester
Prostate
James D. Brooks
Stanford Molecular and Cellular Characterization Laboratory
Prostate
Paul Tempst
Immobilized protease activity tests for developing functional cancer biomarkers.
Prostate
Harry Ostrer
Genomics and Predictive Modeling of Prostate Cancer Heath Disparity
Prostate
Tony R Hunter
Signal Transduction by Tyrosine Phosphorylation
Prostate
Dario C Altieri
Control of Apoptosis in Cancer by Survivin
Prostate
Pathology
Jeffrey Gildersleeve
Serum Antibody Profiling with a Carbohydrate Microarray
Prostate
Pathology
Liuqing Yang
Mechanistic Roles of Long mcRNA-regulated Gene Transcription in Prostate Cancer
Prostate
